Skyscape Web Viewer : TNM Cancer Staging Manual : Main Index

View All
Neuroendocrine tumors of the small bowel: Kaplan-Meier survival curves by the 8th Edition proposed clinical stage, with a follow-up time of 3 years (2010-2013) and adjusted for patient age
Neuroendocrine tumors of the small bowel: Kaplan-Meier survival curves with 95% confidence intervals by 8th Edition pathological Stage I, n = 142/3366 Data from the National Cancer Data Base (diagnosis years 2010-2013), adjusted for patient age
Neuroendocrine tumors of the small bowel: Kaplan-Meier survival curves with 95% confidence intervals by 8th Edition pathological Stage II, n = 281/3366 Data from the National Cancer Data Base (diagnosis years 2010-2013), adjusted for patient age
Neuroendocrine tumors of the small bowel: Kaplan-Meier survival curves with 95% confidence intervals by 8th Edition pathological Stage III, n =2,136/3366
Neuroendocrine tumors of the small bowel: Kaplan-Meier survival curves with 95% confidence intervals by 8th Edition pathological Stage IV, n =807/3366
Neuroendocrine tumors of the small bowel: Kaplan-Meier survival curves with 95% confidence intervals by the 8th Edition proposed clinical Stage I, n =269/1855
Neuroendocrine tumors of the small bowel: Kaplan-Meier survival curves with 95% confidence intervals by the 8th Edition proposed clinical Stage II, n =240/1855
Neuroendocrine tumors of the small bowel: Kaplan-Meier survival curves with 95% confidence intervals by the 8th Edition proposed clinical Stage III, n =617/1855
Neuroendocrine tumors of the small bowel: Kaplan-Meier survival curves with 95% confidence intervals by the 8th Edition proposed clinical Stage IV, n =729/1855
Neurokinin A (NKA) Neuroendocrine Tumors of the Colon and Rectum Neuroendocrine Tumors of the Jejunum and Ileum
Neuro-oncology chemotherapy radiation therapy
New oral anticoagulation agents (NOAC)
New York Heart Association (NYHA)
Nilotinib
NOAC
Non Hodgkin lymphoma (NHL) Lugano classification pediatric\|AJCC prognostic stage groups pediatric\|prognostic factors
Nonsteroidal anti-inflammatory drugs (NSAIDs)
Norepinephrine
North American Neuroendocrine Tumor Society (NANETS) Neuroendocrine Tumors of the Colon and Rectum Neuroendocrine Tumors of the Jejunum and Ileum
Novel oral anticoagulation agents (NOACs), for stroke
NPC
NSAIDs
NYHA
OAC
OALs
Observed and overall survival rates for 1,278 patients with urethral cancer classified by the current AJCC staging classification
Observed melanoma-related overall Kaplan-Meier survival rates for metastatic primary choroidal and ciliary body melanomas
Observed melanoma-related overall Kaplan-Meier survival rates for nonmetastatic primary choroidal and ciliary body melanomas3
Observed survival rates for 21,904 cases with carcinoma of the corpus uterus
Obturator lymph nodes cervix uteri fallopian tube ovary and primary peritoneal carcinoma penis Vagina

NDX